Title : Everolimus suppresses invasion and migration of renal cell carcinoma by inhibiting FAK activity and reversing epithelial to mesenchymal transition in vitro and in vivo.

Pub. Date : 2017 Jul

PMID : 28258630






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Everolimus (EVE), an m-TOR inhibitor, has the potential to inhibit tumor progression at multiple levels and is indicated for the treatment of advanced RCC in patients whose disease has metastasis. Everolimus RAR related orphan receptor C Homo sapiens